drugset / Trial / NCT02177305
Dose Tolerance Study After Ocular Administration of Tiotropium in Healthy Male Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
Safety and tolerability after ocular administration
Timeline
- Start
- 1998-10
- Primary completion
- 1998-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tiotropium | Other / unclassified | 0.02 ug | Other |
| Subject | Tiotropium | Other / unclassified | 0.04 ug | Other |
| Subject | Tiotropium | Other / unclassified | 0.08 ug | Other |
| Subject | Tiotropium | Other / unclassified | 0.16 ug | Other |
| Subject | Tiotropium | Other / unclassified | 0.28 ug | Other |
| Subject | Tiotropium | Other / unclassified | 0.4 ug | Other |
Indications
No indication recorded.